Atlas Trials

Early Detection of Patients at Risk of Developing Anthracycline Cardiotoxicity With TEP/CT -FDG

Clinical trial NCT04892667 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04892667
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Lymphoma, Non-HodgkinLymphoma, Hodgkin
Start date
2022-04-01
Primary completion
2026-03-17
Enrollment
128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.